Prof. Dr. med. Hans-Ulrich Schildhaus

 
Staff Status
exunigoe
 

1-38 of 38
 
The bibliographical data in your publication list are complete
You can correct existing data in the blue highlighted fields.To do this, please click on the coloured field. It is not possible to delete data here.
Fields that are not marked in colour (e. g. the authors) can be edited using the input form. To do so, click on the in front of the respective publication.
The bibliographic data in your publication list may be incomplete. You can
  • add any missing data in the fields marked in red or
  • correct existing data in the blue highlighted fields.
To do this, please click on the coloured field. It is not possible to delete data here.
Fields that are not marked in colour (e. g. the authors) can be edited using the input form. To do so, click on the in front of the respective publication.
Check/Uncheck all
  • 2021 Journal Article | Research Paper | 
    ​ ​An unusual lymphoid lesion mimicking meningioma​
    Abboud, T. ; Stork, L.; Schildhaus, H. ; Stadelmann, C. ; Rohde, V.   & Mielke, D. ​ (2021) 
    Brain Pathology31(5).​ DOI: https://doi.org/10.1111/bpa.12995 
    Details  DOI 
  • 2021 Journal Article
    ​ ​Polyclonal on- and off-target resistance mutations in an EML4-ALK positive non-small cell lung cancer patient under ALK inhibition​
    Kemper, M.; Evers, G.; Schulze, A. B.; Sperveslage, J.; Schülke, C.; Lenz, G. & Herold, T. et al.​ (2021) 
    Oncotarget12(19) pp. 1946​-1952​.​ DOI: https://doi.org/10.18632/oncotarget.28062 
    Details  DOI 
  • 2020 Journal Article
    ​ ​Statistical modelling of HER2-positivity in breast cancer: Final analyses from two large, multicentre, non-interventional studies in Germany​
    Rüschoff, J. ; Lebeau, A.; Sinn, P.; Schildhaus, H.-U. ; Decker, T.; Ammann, J. & Künzel, C. et al.​ (2020) 
    The Breast49 pp. 246​-253​.​ DOI: https://doi.org/10.1016/j.breast.2019.12.005 
    Details  DOI 
  • 2020 Journal Article | 
    ​ ​Top-level MET gene copy number gain defines a subtype of poorly differentiated pulmonary adenocarcinomas with poor prognosis​
    Overbeck, T. R.; Cron, D. A.; Schmitz, K.; Rittmeyer, A.; Körber, W.; Hugo, S. & Schnalke, J. et al.​ (2020) 
    Translational Lung Cancer Research9(3) pp. 603​-616​.​ DOI: https://doi.org/10.21037/tlcr-19-339 
    Details  DOI 
  • 2020 Journal Article
    ​ ​A noninterventional, multinational study to assess PD‐L1 expression in cytological and histological lung cancer specimens​
    Bubendorf, L.; Conde, E.; Cappuzzo, F.; Langfort, R.; Schildhaus, H. ; Votruba, J. & Concha‐López, Á. et al.​ (2020) 
    Cancer Cytopathology128(12) pp. 928​-938​.​ DOI: https://doi.org/10.1002/cncy.22324 
    Details  DOI 
  • 2020 Journal Article | 
    ​ ​Treatment response to idelalisib in a patient with immunodeficiency-associated Burkitt lymphoma harboring a PIK3CA H1047R mutation​
    Bleckmann, A. ; Dierks, S.; Schildhaus, H.-U. ; Hellige, N.; Bacher, U. ; Trümper, L.   & Wulf, G. ​ (2020) 
    Annals of Hematology,.​ DOI: https://doi.org/10.1007/s00277-020-03974-y 
    Details  DOI 
  • 2020 Journal Article | 
    ​ ​Fibroblast growth factor receptor 1 gene amplification and protein expression in human lung cancer​
    Elakad, O.; Lois, A.; Schmitz, K.; Yao, S.; Hugo, S.; Lukat, L. & Hinterthaner, M.  et al.​ (2020) 
    Cancer Medicine9(10) pp. 3574​-3583​.​ DOI: https://doi.org/10.1002/cam4.2994 
    Details  DOI 
  • 2020 Journal Article | 
    ​ ​KRAS mutation status concordance between the primary tumor and the corresponding metastasis in patients with rectal cancer​
    Jo, P. ; Bernhardt, M. ; Nietert, M. ; König, A. ; Azizian, A. ; Schirmer, M. A.   & Grade, M.  et al.​ (2020) 
    PLoS One15(10) pp. e0239806​.​ DOI: https://doi.org/10.1371/journal.pone.0239806 
    Details  DOI 
  • 2019 Journal Article
    ​ ​Safety and Efficacy of Crizotinib in Patients With Advanced or Metastatic ROS1-Rearranged Lung Cancer (EUCROSS): A European Phase II Clinical Trial​
    Michels, S.; Massutí, B.; Schildhaus, H.-U. ; Franklin, J.; Sebastian, M.; Felip, E. & Grohé, C. et al.​ (2019) 
    Journal of Thoracic Oncology14(7) pp. 1266​-1276​.​ DOI: https://doi.org/10.1016/j.jtho.2019.03.020 
    Details  DOI 
  • 2019 Journal Article
    ​ ​Regulation and Role of GLI1 in Cutaneous Squamous Cell Carcinoma Pathogenesis​
    Pyczek, J. ; Khizanishvili, N.; Kuzyakova, M.; Zabel, S.; Bauer, J.; Nitzki, F. & Emmert, S.  et al.​ (2019) 
    Frontiers in Genetics10.​ DOI: https://doi.org/10.3389/fgene.2019.01185 
    Details  DOI 
  • 2019 Journal Article
    ​ ​Automated density-based counting of FISH amplification signals for HER2 status assessment​
    Höfener, H.; Homeyer, A.; Förster, M.; Drieschner, N.; Schildhaus, H.-U.   & Hahn, H. K.​ (2019) 
    Computer Methods and Programs in Biomedicine173 pp. 77​-85​.​ DOI: https://doi.org/10.1016/j.cmpb.2019.03.006 
    Details  DOI 
  • 2019 Journal Article
    ​ ​KIT-Dependent and KIT-Independent Genomic Heterogeneity of Resistance in Gastrointestinal Stromal Tumors — TORC1/2 Inhibition as Salvage Strategy​
    Mühlenberg, T.; Ketzer, J.; Heinrich, M. C.; Grunewald, S.; Marino-Enriquez, A.; Trautmann, M. & Hartmann, W. et al.​ (2019) 
    Molecular Cancer Therapeutics18(11) pp. 1985​-1996​.​ DOI: https://doi.org/10.1158/1535-7163.MCT-18-1224 
    Details  DOI 
  • 2019 Journal Article
    ​ ​Loss of RNF40 Decreases NF-B Activity in Colorectal Cancer Cells and Reduces Colitis Burden in Mice​
    Kosinsky, R. L. ; Chua, R. L.; Qui, M.; Saul, D. ; Mehlich, D.; Ströbel, P.   & Schildhaus, H.-U.  et al.​ (2019) 
    Journal of Crohn's and Colitis13(3) pp. 362​-373​.​ DOI: https://doi.org/10.1093/ecco-jcc/jjy165 
    Details  DOI  PMID  PMC  WoS 
  • 2019 Journal Article
    ​ ​Monitoring efficacy of checkpoint inhibitor therapy in patients with non-small-cell lung cancer​
    Schiwitza, A.; Schildhaus, H.-U. ; Zwerger, B.; Rüschoff, J. ; Reinhardt, C.; Leha, A.   & Andreas, S.  et al.​ (2019) 
    Immunotherapy11(9) pp. 769​-782​.​ DOI: https://doi.org/10.2217/imt-2019-0039 
    Details  DOI 
  • 2018 Book Chapter
    ​ ​Using RNA-Seq Data for the Detection of a Panel of Clinically Relevant Mutations​
    Wolff, A. ; Perera-Bel, J. ; Schildhaus, H.-U. ; Homayounfar, K. ; Schatlo, B. ; Bleckmann, A.  & Beißbarth, T. ​ (2018)
    In: German Medical Data Sciences: A Learning Healthcare System pp. 217​-221. 
    Details 
  • 2018 Journal Article
    ​ ​Dramatic Response of a PD-L1–Positive Advanced Angiosarcoma of the Scalp to Pembrolizumab​
    Hamacher, R.; Kämpfe, D.; Reuter-Jessen, K. ; Pöttgen, C.; Podleska, L. E.; Farzaliyev, F. & Steinau, H.-U. et al.​ (2018) 
    JCO Precision Oncology,(2) pp. 1​-7​.​ DOI: https://doi.org/10.1200/PO.17.00107 
    Details  DOI 
  • 2018 Journal Article
    ​ ​CIC fusion-positive sarcoma of the spermatic cord​
    Bremmer, F. ; Fichtner, A.; Triefenbach, R.; Inniger, R.; Mayer, P.; Lukat, L. & Ströbel, P.  et al.​ (2018) 
    Virchows Archiv474(2) pp. 253​-257​.​ DOI: https://doi.org/10.1007/s00428-018-2471-5 
    Details  DOI 
  • 2018 Journal Article
    ​ ​Canonical WNT/β-Catenin Signaling Plays a Subordinate Role in Rhabdomyosarcomas​
    Ragab, N.; Viehweger, F.; Bauer, J.; Geyer, N.; Yang, M.; Seils, A. & Belharazem, D. et al.​ (2018) 
    Frontiers in Pediatrics6.​ DOI: https://doi.org/10.3389/fped.2018.00378 
    Details  DOI 
  • 2018 Journal Article | 
    ​ ​Expression of cell cycle regulators and frequency of TP53 mutations in high risk gastrointestinal stromal tumors prior to adjuvant imatinib treatment​
    Ihle, M. A.; Huss, S.; Jeske, W.; Hartmann, W.; Merkelbach-Bruse, S.; Schildhaus, H.-U.   & Büttner, R. et al.​ (2018) 
    PLoS One13(2) pp. e0193048​.​ DOI: https://doi.org/10.1371/journal.pone.0193048 
    Details  DOI 
  • 2018 Journal Article
    ​ ​Der prädiktive Wert der PD-L1-Diagnostik​
    Schildhaus, H.-U. ​ (2018) 
    Der Pathologe39(6) pp. 498​-519​.​ DOI: https://doi.org/10.1007/s00292-018-0507-x 
    Details  DOI 
  • 2018 Journal Article
    ​ ​FGFR3-Überexpression ist eine relevante Alteration in kolorektalen Karzinomen​
    Fromme, J. E. & Schildhaus, H.-U. ​ (2018) 
    Der Pathologe39(S2) pp. 189​-192​.​ DOI: https://doi.org/10.1007/s00292-018-0504-0 
    Details  DOI 
  • 2018 Journal Article
    ​ ​Optimization and validation of PD-L1 immunohistochemistry staining protocols using the antibody clone 28-8 on different staining platforms​
    Koppel, C.; Schwellenbach, H.; Zielinski, D.; Eckstein, S.; Martin-Ortega, M.; D’Arrigo, C. & Schildhaus, H.-U.  et al.​ (2018) 
    Modern Pathology31(11) pp. 1630​-1644​.​ DOI: https://doi.org/10.1038/s41379-018-0071-1 
    Details  DOI 
  • 2017 Journal Article
    ​ ​Diagnostic red flags: steroid-treated malignant CNS lymphoma mimicking autoimmune inflammatory demyelination​
    Barrantes-Freer, A. ; Engel, A. S.; Rodríguez-Villagra, O. A.; Winkler, A. ; Bergmann, M.; Mawrin, C. & Kuempfel, T. et al.​ (2017) 
    Brain Pathology28(2) pp. 225​-233​.​ DOI: https://doi.org/10.1111/bpa.12496 
    Details  DOI 
  • 2017 Journal Article
    ​ ​Interlaboratory concordance of PD-L1 immunohistochemistry for non-small-cell lung cancer​
    Scheel, A. H; Baenfer, G.; Baretton, G.; Dietel, M.; Diezko, R.; Henkel, T. & Heukamp, L. C et al.​ (2017) 
    Histopathology72(3) pp. 449​-459​.​ DOI: https://doi.org/10.1111/his.13375 
    Details  DOI 
  • 2017 Journal Article
    ​ ​Interlaboratory-concordance of PD-L1 IHC for NSCLC.​
    Scheel, A. H.; Bänfer, G.; Baretton, G. B.; Dietel, M.; Diezko, R.; Henkel, T. & Heukamp, L. C. et al.​ (2017) 
    Journal of Clinical Oncology35(15_suppl) pp. e20508​-e20508​.​ DOI: https://doi.org/10.1200/JCO.2017.35.15_suppl.e20508 
    Details  DOI 
  • 2017 Journal Article
    ​ ​EGFR immunohistochemistry as biomarker for antibody-based therapy of squamous NSCLC – Experience from the first ring trial of the German Quality Assurance Initiative for Pathology (QuIP ® )​
    Petersen, I.; Dietel, M.; Geilenkeuser, W. J.; Mireskandari, M.; Weichert, W.; Steiger, K. & Scheel, A. H. et al.​ (2017) 
    Pathology - Research and Practice213(12) pp. 1530​-1535​.​ DOI: https://doi.org/10.1016/j.prp.2017.09.021 
    Details  DOI 
  • 2017 Journal Article
    ​ ​Context-Dependent Epigenetic Regulation of Nuclear Factor of Activated T Cells 1 in Pancreatic Plasticity​
    Chen, N.-M. ; Neeße, A. ; Dyck, M. L.; Steuber, B. ; König, A. O. ; Lubeseder-Martellato, C. & Winter, T. et al.​ (2017) 
    Gastroenterology152(6) pp. 1507​-+​.​ DOI: https://doi.org/10.1053/j.gastro.2017.01.043 
    Details  DOI  PMID  PMC  WoS 
  • 2016 Journal Article | Research Paper | 
    ​ ​Partielles Ansprechen auf Crizotinib als Erstlinientherapie bei einem älteren männlichen Patienten mit ROS1-Translokations-positivem Bronchialkarzinom​
    Overbeck, T. R. ; Schmitz, K.; Engelke, C.; Sahlmann, C.-O. ; Hugo, S.; Kellner, L. & Trümper, L.  et al.​ (2016) 
    Karger-Kompass Onkologie3(2) pp. 97​-100​.​ DOI: https://doi.org/10.1159/000449192 
    Details  DOI 
  • 2016 Journal Article
    ​ ​HR23b expression is a potential predictive biomarker for HDAC inhibitor treatment in mesenchymal tumours and is associated with response to vorinostat​
    Angelika Ihle, M.; Merkelbach‐Bruse, S.; Hartmann, W.; Bauer, S. ; Ratner, N.; Sonobe, H. & Nishio, J. et al.​ (2016) 
    The Journal of Pathology2(2) pp. 59​-71​.​ DOI: https://doi.org/10.1002/cjp2.v2.2 
    Details  DOI 
  • 2016 Journal Article
    ​ ​Partial Response to First-Line Crizotinib in an Elderly Male Patient with ROS1 Translocation-Positive Lung Cancer​
    Overbeck, T. R. ; Schmitz, K.; Engelke, C.; Sahlmann, C.-O. ; Hugo, S.; Kellner, L. & Trümper, L.  et al.​ (2016) 
    Case Reports in Oncology9(1) pp. 158​-163​.​ DOI: https://doi.org/10.1159/000444745 
    Details  DOI 
  • 2016 Journal Article
    ​ ​Heterogeneous Mechanisms of Primary and Acquired Resistance to Third-Generation EGFR Inhibitors​
    Ortiz-Cuaran, S.; Scheffler, M.; Plenker, D.; Dahmen, I.; Scheel, A. H.; Fernandez-Cuesta, L. & Meder, L. et al.​ (2016) 
    Clinical Cancer Research22(19) pp. 4837​-4847​.​ DOI: https://doi.org/10.1158/1078-0432.CCR-15-1915 
    Details  DOI  PMID  PMC  WoS 
  • 2016 Journal Article
    ​ ​Clinicopathological Characteristics of RET Rearranged Lung Cancer in European Patients​
    Michels, S.; Scheel, A. H. J.; Scheffler, M.; Schultheis, A. M.; Gautschi, O. P.; Aebersold, F. & Diebold, J. et al.​ (2016) 
    Journal of Thoracic Oncology11(1) pp. 122​-+​.​ DOI: https://doi.org/10.1016/j.jtho.2015.09.016 
    Details  DOI  PMID  PMC  WoS 
  • 2016 Journal Article
    ​ ​Occurrence of PDL1/2 copy number gains detected by FISH in adeno and squamous cell carcinomas of the lung and association with PDL1 overexpression in adenocarcinomas.​
    Schildhaus, H.-U. ; Richardt, P.; Wilsberg, L. & Schmitz, K.​ (2016) 
    Journal of Clinical Oncology34(15_suppl) pp. 3031​-3031​.​ DOI: https://doi.org/10.1200/JCO.2016.34.15_suppl.3031 
    Details  DOI 
  • 2016 Journal Article
    ​ ​Diagnostic PD-L1 immunohistochemistry in NSCLC: Results of the first German harmonization study.​
    Scheel, A. H.; Dietel, M.; Heukamp, L. C.; Jöhrens, K.; Kirchner, T.; Reu, S. & Ruschoff, J.  et al.​ (2016) 
    Journal of Clinical Oncology34(15_suppl) pp. 3028​-3028​.​ DOI: https://doi.org/10.1200/JCO.2016.34.15_suppl.3028 
    Details  DOI 
  • 2015 Journal Article
    ​ ​MET Amplification Status in Therapy-Naive Adeno- and Squamous Cell Carcinomas of the Lung​
    Schildhaus, H.-U. ; Schultheis, A. M.; Rüschoff, J. R. ; Binot, E.; Merkelbach-Bruse, S.; Fassunke, J. & Schulte, W. et al.​ (2015) 
    Clinical Cancer Research21(4) pp. 907​-915​.​ DOI: https://doi.org/10.1158/1078-0432.CCR-14-0450 
    Details  DOI  PMID  PMC  WoS 
  • 2015 Conference Abstract
    ​ ​Heterogeneity of colorectal cancer liver metastasis - analysis of WNT pathway patterns via High-throughput and bioinformatics profiling​
    Bleckmann, A. ; Wachter, A. ; Conradi, L.-C. ; Wolff, A. ; Hoppenau, C.; Korf, U. & Schildhaus, H.-U.  et al.​ (2015)
    Oncology Research and Treatment38 
    Basel​: Karger.
    Details  WoS 
  • 2014 Conference Abstract
    ​ ​ROS1 rearrangement in non-small cell lung cancer (NSCLC): Prognostic and predicitve impact and genetic variability​
    Scheffler, M.; Schultheis, A.; Michels, S.; Teixido, C.; Hartmann, W.; Merkelbach-Bruse, S. & Sebastian, M. et al.​ (2014)
    Oncology Research and Treatment37 
    Basel​: Karger.
    Details  WoS 
  • 2010 Journal Article | 
    ​ ​Pitfall in mutational testing and reporting of common KIT and PDGFRA mutations in gastrointestinal stromal tumors​
    Merkelbach-Bruse, S.; Dietmaier, W.; Fuezesi, L.; Gaumann, A.; Haller, F.; Kitz, J. & Krohn, A. et al.​ (2010) 
    BMC Medical Genetics11 art. 106​.​ DOI: https://doi.org/10.1186/1471-2350-11-106 
    Details  DOI  PMID  PMC  WoS 

Publication List

Type

Subtype

Date issued

Author

Peer-Reviewed

Organization

Language

Fulltext

Options

Citation Style

https://publications.goettingen-research-online.de URI: /cris/rp/rp44610
ID: 0000000
PREF: default TOKEN:

0

Sort

Issue Date
Title

Embed

JavaScript
Link

Export

Activate Export Mode
Deactivate Export Mode

Select some or all items (max. 800 for CSV/Excel) from the publications list, then choose an export format below.